期刊文献+

布洛芬微晶体在口腔崩解片中的应用

Disintegration behavior of ibuprofen microcrystal from orally disintegrating tablets
下载PDF
导出
摘要 目的:改善口腔崩解片干粉压片工艺中药物的可压性、流动性、黏冲性,提高崩解片的崩解速度。方法:以布洛芬为模型药物,利用溶剂一非溶剂法改变其结晶形态,获得5种不同的微晶体,并用扫描电镜(SEM)和X衍射仪(XRD)表征。通过各晶体的压片工艺性能测试及压片后的崩解实验,优选出性能良好的晶体,并对其压制的崩解片进行了体外溶出性能的测定。结果:优选出的微晶体具有良好的可压性、流动性和抗黏冲性能,压片后崩解时限大大缩短,溶出度也有一定的提高。结论:优选出的布洛芬微晶体改善了口腔崩解片的整体性能。 Objective: To improve the tablet disintegration by selecting ap of drug powders to prepare orally disintegrating tablets. Methods: Five types of propriate microcrystal buprofen microcrystal were made by solvent-nonsolvent crystallization technique. The microcrystal was characterized by scanned electronic microscopy (SEM) and X-ray detector (XRD), respectively. The optimal crystals were obtained by the feature tests of compressibility and flowability and the dissolution test of the orally disintegrating tables. Results: The optimal microcrystal had better compressibility, flowability and resistance to sticking to a die well. The orally integrating tablets made of the optimal microcrystal showed improved dissolution and solubility. Conclusion : The optimal microcrystal improved the integrated behavior of ibuprofen orally disintegrating tablet.
作者 周政 张奇
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第16期1374-1377,共4页 Chinese Journal of New Drugs
基金 北京理工大学基础基金研究项目(20050584225)
关键词 晶体形态 布洛芬 微晶体 口腔崩解片 crystal morphology ibuprofen microcrystal orally disintegrating tablet
  • 相关文献

参考文献9

  • 1冯志强,邓伟,郭宗儒.药物研究与开发中的高通量结晶技术[J].药学学报,2005,40(6):481-485. 被引量:6
  • 2黄林.现代近红外光谱分析技术在制药工业及临床医学中的应用[J].生命科学仪器,2004,2(6):52-53. 被引量:3
  • 3冒莉,郑启泰,吕扬.固体药物多晶型的研究进展[J].天然产物研究与开发,2005,17(3):371-375. 被引量:48
  • 4RASENACK N,MüLLER BW.Ibuprofen crystal with optimized properties[J].Int J Pharm,2002,245(1/2):9 -24.
  • 5MARTINO PD,BECCERICA M,JOIRIS E,et al.Influence of crystal habit on the compression and densification mechanism of ibuprofen[J].J Cryst Growth,2002,243(2):345 -355.
  • 6NIKOLAKAKIS I,KACHRIMANIS K,MALAMATARIS S,et al.Relation between crystallization conditions and micrometric properties of ibuprofen[J].Int J Pharm,2000,201 (1):79-88.
  • 7RASENACK N,MüLLER W.Crystal habit and tableting behavior[J].Int J Pharm,2002,244(1/2):45 -57.
  • 8MANISH M,HARSHAL J,ANANT P.Melt sonocrystallization of ibuprofen:Effect on crystal properties[J].Eur J Pharm Sci,2005,25 (1):41-48.
  • 9RASENACK N,STECKEL H,MüLLER BW.Preparation of microcrystals by in situ micronization[J].Powder Technology,2004,143-144:291-296.

二级参考文献33

  • 1王晋,张汝华,孙淑英.尼莫地平多晶型的研究[J].药学学报,1995,30(6):443-448. 被引量:27
  • 2Davey RJ, Allen K, Blagden N, et al. Crystal engineering-nucleation, the key step [J]. Cryst Eng Comm, 2002,4(47):257-264.
  • 3Leiserowitz L. To monitor and control nucleation of molecular crystals [R]. Abstr.-Am Chem Soc, 2002,223:1. Orlendo FL USA. America Chemical Sociely, 2002.
  • 4Dunitz JD. Are crystal structures predictable? [J]. Chem Commun, 2003,5:545-548.
  • 5Peterson ML, Morissette SL, McNulty C, et al. Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form Ⅲ [J]. J Am Chem Soc, 2002,124(37):10958-10959.
  • 6Storey RA, Docherty R, Higginson PD. Integration of high-throughput screening methodologies and manual processes for solid form selection [J]. Am Pharm Rev, 2003,Spring:100-105.
  • 7Carlson ED, Cong P, Chandler WH, et al. Apparatuses and methods for creating and testing pre-formulations and systems for same [P]. US Pat: 0116497, 2003-06-26.
  • 8Desrosiers P, Carlson E, Chandler W, et al. High-throughput screening techniques for preformulation: salt selection and polymorph studies [J]. Acta Cryst A, 2002,58(Suppl):C9.
  • 9Almarsson O. High-throughput crystallization technology for polymorphism studies of pharmaceuticals, Scientific Update [R]. Int Symp Polymorp and Cryst. UK: Chester, 2003.
  • 10Mitchell CA, Yu L, Ward MD. Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates [J]. J Am Chem Soc, 2001,123:10830-10839.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部